Repligen
RGEN
#2563
Rank
NZ$11.55 B
Marketcap
NZ$205.09
Share price
5.68%
Change (1 day)
-7.90%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): NZ$0.14 Billion

According to Repligen 's latest financial reports the company's current earnings are NZ$0.73 Billion. , an increase over its 2024 earnings that were of -NZ$10.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.14 B-1430.84%
2024 -NZ$10.98 Million-113.01%
2023 NZ$84.33 M-78.01%
2022 NZ$0.38 B33.37%
2021 NZ$0.28 B131.52%
2020 NZ$0.12 B101.31%
2019 NZ$61.69 M25.93%
2018 NZ$48.99 M105.61%
2017 NZ$23.82 M-11.46%
2016 NZ$26.91 M14.91%
2015 NZ$23.42 M20.26%
2014 NZ$19.47 M-51.49%
2013 NZ$40.14 M90.98%
2012 NZ$21.02 M
2010 NZ$0.3 M-103.81%
2009 -NZ$7.99 Million-223.84%
2008 NZ$6.44 M
2006 -NZ$4.34 Million229.64%
2005 -NZ$1.32 Million-89.16%
2004 -NZ$12.13 Million-16.86%
2003 -NZ$14.59 Million88.72%
2002 -NZ$7.73 Million-27.88%
2001 -NZ$10.72 Million-1.74%
2000 -NZ$10.91 Million85.93%
1999 -NZ$5.87 Million159.16%
1998 -NZ$2.27 Million85.71%
1997 -NZ$1.22 Million-70.83%
1996 -NZ$4.18 Million-72.41%
1995 -NZ$15.15 Million-60.63%
1994 -NZ$38.47 Million45.39%
1993 -NZ$26.46 Million39.45%
1992 -NZ$18.98 Million-32.3%
1991 -NZ$28.03 Million6.62%
1990 -NZ$26.29 Million1577.78%
1989 -NZ$1.57 Million-57.14%
1988 -NZ$3.66 Million-362.5%
1987 NZ$1.39 M-130.77%
1986 -NZ$4.53 Million136.36%
1985 -NZ$1.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.74 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$12.72 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$18.87 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.23 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-NZ$0.19 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$0.65 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$1.10 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.21 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.83 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-NZ$0.18 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA